VIRPAX PHARMACEUTICALS, INC.

Insiders Virpax Pharmaceuticals, Inc.

Equities

VRPX

US9282512063

Market Closed - Nasdaq Other stock markets 01:30:00 16/05/2024 am IST			5-day change	1st Jan Change
0.78 ^USD	-65.94%		-66.95%	-75.63%

07:59pm	Virpax Prices Public Offering of Shares, Warrants; Shares Tumble	MT
02:16pm	Top Premarket Decliners	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Virpax Pharmaceuticals Announces Leadership Transition	17/11	CI
Virpax Pharmaceuticals, Inc. Announces CEO Changes	17/11	CI
Virpax Names Gerald Bruce as CEO of Novvae Pharmaceuticals Unit	02/23/02	MT
Novvae Pharmaceuticals Announces Executive Appointments	02/23/02	CI
Virpax Pharmaceuticals Names New CFO	21/23/21	MT
Virpax Pharmaceuticals, Inc. Announces Executive Changes	21/23/21	CI
Virpax Pharmaceuticals, Inc. Appoints Barbara Ruskin as Class I Director	08/23/08	CI
Virpax Pharmaceuticals Announces Appointment of Barbara A. Ruskin to the Board of Directors	28/23/28	CI
Virpax Pharmaceuticals, Inc. Announces Board Appointments	30/21/30	CI
Virpax Pharmaceuticals, Inc. Promotes Michèle C. Linde to EVP, Global Corporate Governance, Chief Legal Officer & Corporate Secretary	23/19/23	CI
Virpax Pharmaceuticals, Inc. Appoints Gerald W. Bruce as Executive Vice President, Commercial Operations	18/19/18	CI
Virpax Pharmaceuticals, Inc. Announces Board Appointments	11/19/11	CI
Virpax Pharmaceuticals, Inc. Appoints Michèle C. Linde as the Executive Vice President, General Counsel and Corporate Secretary	12/19/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW